Lineage Cell Therapeutics LCTX
NYSE LCTX
$0.98 +0.03 (+3.16%)
At close: Oct 22, 2026 · 4:00 PM EDT

Lineage Cell Therapeutics (LCTX) Other non-cash items (2010 - 2026)

Updated

Analysis

Lineage Cell Therapeutics (LCTX) Other non-cash items (2010 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn
10 Lineage Cell Therapeutics 247.85 Mn 46.25 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -9.44 Mn
Mar 31, 2026 -2.35 Mn
Dec 31, 2025 -1.81 Mn
Sep 30, 2025 26.56 Mn
Jun 30, 2025 12.74 Mn
Mar 31, 2025 -2.02 Mn
Dec 31, 2024 -2.16 Mn
Dec 31, 2023 -1.89 Mn
Sep 30, 2023 881,000.00
Jun 30, 2023 546,000.00
Mar 31, 2023 465,000.00
Dec 31, 2022 -398,000.00
Sep 30, 2022 337,000.00
Jun 30, 2022 -2,000.00
Mar 31, 2022 -146,000.00
Dec 31, 2021 -1.96 Mn
Sep 30, 2021 -53,000.00
Jun 30, 2021 -558,000.00
Mar 31, 2021 1.71 Mn
Dec 31, 2020 -2.84 Mn
API Access

Lineage Cell Therapeutics Other non-cash items API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-cash-items&ticker=LCTX&period=max&api_key=YOUR_API_KEY